Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Ali Askari, MD

Ali Askari, MD

Office Locations

UH Cleveland Medical Center Mather (0 mi.)

11100 Euclid Ave
Mather Ste 1500
Cleveland, OH 44106

UH Cleveland Minoff Health Center (7 mi.)

3909 Orange Pl
Ste 3200
Beachwood, OH 44122

UH Minoff Health Center (7 mi.)

3909 Orange Pl
Ste 3100
Beachwood, OH 44122

Biography: Ali Askari, MD


  • Diseases of the Muscles
  • Fibromyalgia
  • Lupus
  • Rheumatology - Adult
  • Sjögren’s Syndrome


  • Program Director, Rheumatology, UH Cleveland Medical Center

Certifications & Memberships

  • Rheumatology - American Board of Internal Medicine
  • Internal Medicine - American Board of Internal Medicine


Fellowship | Rheumatology
Rheumatology - University Hospitals Of Cleveland (1972 - 1974)

Residency | Internal Medicine
Internal Medicine - University Hospitals Of Cleveland (1970 - 1972)

Internship | Rotator
Rotator - St Vincent Charity Hospital/St Luke's Medical Cent (1968 - 1969)

Medical Education
Tehran University Of Medical Sciences (1966)


Ali D. Askari, MD, is the immediate past director of the Division of Rheumatology and the Rheumatology Fellowship at University Hospitals, Professor Emeritus of Medicine at Case Western Reserve University School of Medicine and is board-certified in Rheumatology and Internal Medicine. His areas of expertise include fibromyalgia, lupus, Sjögren’s syndrome, rheumatoid arthritis, inflammatory myopathies and other adult rheumatological diseases. During his more than 50-year career at UH, Dr. Askari has distinguished himself as a leading physician, teacher and researcher in the field of rheumatology.

Dr. Askari earned his medical degree at Tehran University in Tehran, Iran. He completed his residency in internal medicine and a fellowship in rheumatology at UH/Case Western Reserve University, where he served as chief resident.

Dr. Askari has been an active staff member at UH since 1974 and spent 20 years as director of the rheumatology fellowship program at UH/Case Western Reserve University. During his years as division and fellowship director, Dr. Askari trained 100 rheumatologists who are now academic practitioners all over the world. He continues with his teaching and instruction of fellows at UH and Case Western Reserve University.

Through his research, Dr. Askari has made significant academic contributions in the areas of complications of myopathies, neuromuscular problems with Sjögren’s syndrome, innovative treatment of relapsing polychondritis, the first treatment of Behcet’s disease with Colchicine in the U.S., complications of joint hypermobility, the similarity of periodontis to rheumatoid arthritis, and the treatment of these refractory conditions. Dr. Askari’s prolific research has resulted in the publication of more than 50 articles and numerous abstracts in prominent medical journals.

Dr. Askari has been an active member of numerous committees and professional organizations throughout his career. He served as president of the board of directors for the National Sjogren’s Syndrome Association, is a member of the American Medical Association, and was on the board of directors for Academy of Medicine for two terms. He was the chairman of the Lupus Foundation, vice president of the Arthritis Foundation Cleveland chapter, and served as president of the Cleveland Society of Rheumatology twice. He is a founding fellow of the American College of Rheumatology and a fellow of the American College of Physicians.

Awards and achievements that Dr. Askari has earned throughout his career include the American College of Rheumatology Masters Award, Top Physicians Award, and the Who’s Who Among Outstanding Americans. In 2019, he was named a University Hospitals Distinguished Physician, an honor bestowed on only a select few UH physicians each year.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Ali Askari did not disclose any Outside Relationships with Industry.